Melanoma in a patient with DNMT3A overgrowth syndrome

DY Chen, LA Sutton… - Molecular …, 2023 - molecularcasestudies.cshlp.org
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …

Melanoma in a patient with DNMT3A overgrowth syndrome

DY Chen, LA Sutton, SM Ramakrishnan… - Cold Spring Harbor …, 2023 - profiles.wustl.edu
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …

[HTML][HTML] Melanoma in a patient with DNMT3A overgrowth syndrome

DY Chen, LA Sutton, SM Ramakrishnan… - Cold Spring Harbor …, 2023 - ncbi.nlm.nih.gov
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …

Melanoma in a patient with DNMT3A overgrowth syndrome.

DY Chen, LA Sutton… - Cold Spring Harbor …, 2023 - search.ebscohost.com
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …

Melanoma in a patient with DNMT3A overgrowth syndrome

DY Chen, LA Sutton… - Cold Spring …, 2023 - pubmed.ncbi.nlm.nih.gov
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …

Melanoma in a patient with DNMT3A overgrowth syndrome.

DY Chen, LA Sutton, SM Ramakrishnan… - Cold Spring Harbor …, 2023 - europepmc.org
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …

[PDF][PDF] Melanoma in a patient with DNMT3A overgrowth syndrome

DY Chen, LA Sutton, SM Ramakrishnan… - 2023 - digitalcommons.wustl.edu
Alterations in epigenetic regulators are increasingly recognized as early events in
tumorigenesis; thus, patients with acquired or inherited variants in epigenetic regulators may …